Armata Shares Rise After Additional $2.5M Department of Defense Award
Armata Pharmaceuticals saw a 7.7% gain in premarket trading after the Department of Defense provided an additional $2.5 million in non-dilutive funding. The award, now totaling $28.7 million, is administered through the Medical Technology Enterprise Consortium and supports late-stage development and Phase 3 readiness activities for AP-SA02, the com…